Research Paper Volume 13, Issue 23 pp 25271—25290

An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (MSH6) in human tumors


Figure 4. Phosphorylation differences of MSH6 protein in various cancers of TCGA. Based on the CPTAC dataset, the expression differences of MSH6 phosphoprotein (NP_000170.1, S14, S137, S200, S219, S227, S261, S309, and S830 sites) between normal tissue and tumor tissue from selected tumors were detected through the UALCAN. (A) Breast cancer. (B) Colon cancer. (C) LUAD. (D) Clear cell RCC. (E) Ovarian cancer. (F) UCEC.